TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,347,761 | +21.4% | 188,394 | +23.4% | 0.00% | 0.0% |
Q2 2023 | $2,758,638 | +57.7% | 152,664 | +9.7% | 0.00% | 0.0% |
Q1 2023 | $1,749,128 | -13.9% | 139,151 | +0.4% | 0.00% | 0.0% |
Q4 2022 | $2,031,158 | -13.0% | 138,551 | +1.6% | 0.00% | 0.0% |
Q3 2022 | $2,335,000 | +72.5% | 136,380 | +47.1% | 0.00% | – |
Q2 2022 | $1,354,000 | +65.5% | 92,733 | +90.9% | 0.00% | – |
Q1 2022 | $818,000 | -23.0% | 48,583 | +3.0% | 0.00% | – |
Q4 2021 | $1,062,000 | +5.4% | 47,181 | +0.9% | 0.00% | – |
Q3 2021 | $1,008,000 | -25.3% | 46,766 | +0.4% | 0.00% | – |
Q2 2021 | $1,350,000 | +0.6% | 46,573 | +11.9% | 0.00% | – |
Q1 2021 | $1,342,000 | -12.8% | 41,623 | +11.8% | 0.00% | -100.0% |
Q4 2020 | $1,539,000 | – | 37,223 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |